LUM/IVA

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Vertex Pharmaceuticals Incorporated

Overview

LUM/IVA is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 4 tracked IPF clinical trials.

LUM/IVA clinical trials

NCT02875366 (Phase 4)NCT02797132 (Phase 3)NCT03125395 (Phase 3)NCT03061331 (Phase 2)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about LUM/IVA for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.